2m 2m 2m 2m 2m 2m 2m
ROYAL PHARM -A (RPRX)
NASDAQ
$58.17-$0.26 (-0.44%)
Price as of Aug 03, 2026 4:57 AM EDT- $26.2BMarket Cap
- 60.83%1-Year Change
- BiotechnologyIndustry
ROYAL PHARM -A (RPRX)
$58.17-$0.26 (-0.44%)
RPRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $58.43 | ||
Change | -$0.59 (-1.00%) | ||
Open | $58.63 | ||
High | $59.12 | ||
Low | $58.26 | ||
Previous Close | $59.02 | ||
Volume | 2,156,869 | ||
30-Day Average Volume | 2,729,328 | ||
1-Week Change | -0.68% | ||
1-Month Change | 4.21% | ||
1-Year Change | 60.83% | ||
3-Year Change | 101.57% | ||
5-Year Change | 71.98% | ||
Fundamentals | |||
Shares Outstanding | 443.2M | ||
Total Assets | $19.8B | ||
Market Cap | $26.2B | ||
Enterprise Value | $34.5B | ||
Period: QTR TTM FY | |||
Revenue | $595.0M | ||
Net Income | $294.7M | ||
Free Cash Flow | $718.2M | ||
EBIT | $294.7M | ||
EBITDA | $295.9M | ||
Net Working Capital | $890.1M | ||
EPS | $0.67 | ||
Enterprise Value/EBITDA | 117 | ||
Enterprise Value/Revenue | 58 | ||
P/B | 3 | ||
P/E | 87 | ||
PEG | 1 | ||
Price/Free Cash Flow | 36 | ||
Price/Operating Cash Flow | 36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.61% | ||
Trailing Annual Dividend Yield | 1.56% | ||
Ex-Dividend Date | 08/14/2026 | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 10/15/2010 | ||
Earnings & Revenue
Annual Dividend Yield